A lifetime of prevention - The case of heart failure

被引：26

作者：

Yusuf, S

Pitt, B

机构：

[1] McMaster Univ, Hamilton, ON, Canada

[2] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2002年 / 106卷 / 24期

关键词：

editorials; heart failure; prevention; risk factors;

D O I：

10.1161/01.CIR.0000046804.13847.5D

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2997 / 2998

页数：2

共 12 条

[1]

ANDERSON B, 2002, IN PRESS EVIDENCE BA

[2] Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials [J].

Connolly, SJ ;

Hallstrom, AP ;

Cappato, R ;

Schron, EB ;

Kuck, KH ;

Zipes, DP ;

Greene, HL ;

Boczor, S ;

Domanski, M ;

Follmann, D ;

Gent, M ;

Roberts, RS .

EUROPEAN HEART JOURNAL, 2000, 21 (24) :2071-2078

[3] Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients [J].

Flather, MD ;

Yusuf, S ;

Kober, L ;

Pfeffer, M ;

Hall, A ;

Murray, G ;

Torp-Pedersen, C ;

Ball, S ;

Pogue, J ;

Moyé, L ;

Braunwald, E .

LANCET, 2000, 355 (9215) :1575-1581

[4]

FURBERG CD, 2002, IN PRESS EVIDENCE BA

[5] Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].

Hjalmarson, Å ;

Goldstein, S ;

Fagerberg, B ;

Wedel, H ;

Waagstein, F ;

Kjekshus, J ;

Wikstrand, J ;

El Allaf, D ;

Vítovec, J ;

Aldershvile, J ;

Halinen, M ;

Dietz, R ;

Neuhaus, KL ;

Jánosi, A ;

Thorgeirsson, G ;

Dunselman, PHJM ;

Gullestad, L ;

Kuch, J ;

Herlitz, J ;

Rickenbacher, P ;

Ball, S ;

Gottlieb, S ;

Deedwania, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302

[6]

JONG P, ENALAPRIL IMPROVES S

[7] Obesity and the risk of heart failure [J].

Kenchaiah, S ;

Evans, JC ;

Levy, D ;

Wilson, PWF ;

Benjamin, EJ ;

Larson, MG ;

Kannel, WB ;

Vasan, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :305-313

[8] Lifetime risk for developing congestive heart failure - The Framingham Heart Study [J].

Lloyd-Jones, DM ;

Larson, MG ;

Leip, EP ;

Beiser, A ;

D'Agostino, RB ;

Kannel, WB ;

Murabito, JM ;

Vasan, RS ;

Benjamin, EJ ;

Levy, D .

CIRCULATION, 2002, 106 (24) :3068-3072

[9] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[10] Long-term use of a left ventricular assist device for end-stage heart failure [J].

Rose, EA ;

Gelijns, AC ;

Moskowitz, AJ ;

Heitjan, DF ;

Stevenson, LW ;

Dembitsky, W ;

Long, JW ;

Ascheim, DD ;

Tierney, AR ;

Levitan, RG ;

Watson, JT ;

Meier, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1435-1443

← 1 2 →